EN
Home/Answers/Sulfur burps
ALLAll countries Side effects and safety

How do I stop sulfur burps on tirzepatide or semaglutide?

What we checked11 sources, each one opened and linked to the sentence it supportsLast checked Nov 9, 2026 · Next review due Nov 9, 2027 · How we write
The short answer

We found no remedy proven to stop sulfur burps on tirzepatide (Mounjaro, Zepbound) or semaglutide (Ozempic, Wegovy). Expert advice for stomach side effects is smaller, low-fat meals. A US bismuth subsalicylate label lists belching from overindulgence, but says stop if symptoms last over 2 days. US label trials show burping in 4% to 5% on Zepbound and 7% on Wegovy.

Why do tirzepatide and semaglutide cause sulfur burps?

Burping is a listed side effect of both medicines, but no label or study we found explains the rotten-egg smell.12

In the US Zepbound label, burping (eructation) affected 4% to 5% on tirzepatide against 1% on placebo.1 The US Wegovy label gives 7% on semaglutide 2.4 mg against under 1%.2

The US Mounjaro label gives 2.5% to 3.3% against 0.4%.3 The US Ozempic label gives 1.1% to 2.7% against 0%.4

These figures cannot show how many burps smelled of sulfur.

Both medicines slow stomach emptying.12 Forum posts raise the idea that food sitting longer lets gut bacteria make hydrogen sulfide. We found no study testing this in people on these medicines.

The UK Wegovy SmPC (product information) says burping was mainly seen during dose increases.5

Which food changes might help?

A 2022 expert consensus on GLP-1 stomach side effects advises smaller portions, low-fat food and stopping when full, in advice for stomach side effects generally.6

It also advises eating slowly and not lying down after a meal.6 For reflux, it advises avoiding alcohol and fizzy drinks.6 Its reflux case, a patient with frequent belching and heartburn, adds a short course of a proton pump inhibitor (acid-reducing medicine).6

The US digestive health institute NIDDK says swallowing less air may ease frequent belching.7 Its tips are to skip gum, hard sweets, fizzy drinks and straws, and to eat more slowly.7

NIDDK says some people get more gas from cruciferous vegetables such as broccoli, legumes such as beans, and foods high in fibre, fructose or lactose.7 We found no trial of a low-sulfur diet in people on these medicines.

Does bismuth subsalicylate help?

A US bismuth subsalicylate (Pepto-Bismol) label lists belching from overindulgence in food and drink as a use, but we found no study of it for sulfur burps on these medicines.8

Hydrogen sulfide is a main odour compound in flatus (wind), and bismuth subsalicylate binds it.9 In a 1998 study of 10 healthy people, bismuth subsalicylate cut hydrogen sulfide release from faeces by over 95%.9 That study measured stool, not burps.9

The US label says not to use it with an ulcer, a bleeding problem, or bloody or black stool.8 It contains salicylate, so it excludes people allergic to aspirin or taking other salicylates.8

It names people taking medicines for diabetes, blood thinning, gout or arthritis as needing professional advice first.8

It says to stop and get medical advice if symptoms worsen or last more than 2 days.8 It also says to stop for ringing in the ears or hearing loss.8 Children and teenagers who have or are recovering from chickenpox or flu-like symptoms should not use it.8 It caps use at 8 doses in 24 hours, and warns of harmless darkening of stool or tongue.8 We opened only this US label, so packs elsewhere may differ.

A US simethicone label lists pressure, bloating and fullness from gas, not belching, for ages 12 and over, with at most 4 softgels in 24 hours.11

What can change if the burps keep coming back?

The US labels let prescribers delay a dose increase or choose a lower maintenance dose when a dose is not tolerated.12

The US Wegovy injection label gives 4 weeks as the delay.2

The 2022 consensus advises against raising the dose while stomach symptoms persist.6 The Zepbound Medication Guide says drinking fluids helps lower the chance of dehydration.1

Severe stomach reactions also occur. The US Zepbound label reports them in 1.7% to 3.1% on tirzepatide against 1% on placebo.1 The US Zepbound and Wegovy labels warn that kidney injury mostly followed vomiting, diarrhoea or nausea with dehydration.12

What do people on GLP-1 medicines report about sulfur burps?

From public patient forums: 586 Reddit threads in r/Zepbound, r/mounjarouk, r/Mounjaro, r/Ozempic, r/WegovyWeightLoss and r/Semaglutide, read from October 2025 to October 2026. Personal reports, not medical evidence.

What people describe

  • Matches the UK label Many say burps begin or worsen after a dose increase. The UK Wegovy SmPC says burping was mainly seen during dose increases.5
  • Not studied Many say burps cluster 1 to 4 days after the weekly dose. We found no study of that timing.
  • Not studied Many describe burps with or before vomiting or diarrhoea. We found no study of that pattern.
  • Matches expert advice Many blame fatty, fried or heavy meals. The 2022 consensus advises low-fat food for stomach side effects, without naming burps.6
  • Not studied Several say burps ease on a settled dose, and several report a first episode after weeks or months on a stable dose. We found no study of either pattern for burping.

Advice people share

  • Not studied Many suggest bismuth subsalicylate, and several say it failed or helped only briefly. We found no study of it for burps on these medicines.
  • Matches expert advice Many suggest smaller meals and stopping at fullness, which the 2022 consensus also advises, without naming burps.6
  • Matches the label Several suggest holding a dose, delaying an increase or stepping down with a prescriber. The US Wegovy label covers delaying an increase, and the US Zepbound label covers a lower maintenance dose. Those lines do not cover holding a dose.12
  • Label says otherwise Several describe non-label dosing, such as splitting doses or partial pen doses. The US Zepbound and Wegovy injection labels give one injection a week.12

In your country

Burping is listed in the US and UK labels we opened, while the brands sold and the labels we could open differ by country.

Australia

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.

Label: We could not open Australia's Product Information, so this page relies on the US labels and the UK SmPC.

Emergency number: 000

Side effects and risks in Australia

Canada

Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.

Label: We could not open Canada's Product Monographs, so this page relies on the US labels and the UK SmPC.

Emergency number: 911

Side effects and risks in Canada

France

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).

Label: We could not open the EU product information used in France, so this page relies on the US labels and the UK SmPC.

Emergency number: 15 or 112

Side effects and risks in France

Germany

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.

Label: We could not open the EU product information used in Germany, so this page relies on the US labels and the UK SmPC.

Emergency number: 112

Side effects and risks in Germany

India

Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).

Label: We did not open an Indian label for this page, so it relies on the US labels and the UK SmPC.

Emergency number: 112

Side effects and risks in India

Saudi Arabia

Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.

Label: We did not open a Saudi label for this page, so it relies on the US labels and the UK SmPC.

Emergency number: 997 or 911

Side effects and risks in Saudi Arabia

United Arab Emirates

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.

Label: We did not open a UAE label for this page, so it relies on the US labels and the UK SmPC.

Emergency number: 998 for an ambulance, or 999

Side effects and risks in the UAE

United Kingdom

Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.

Label: For significant stomach symptoms during Wegovy dose increases, the UK Wegovy SmPC says to consider delaying the increase or lowering to the previous dose.5

Emergency number: 999

Side effects and risks in the UK

United States

Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).

Label: The answer above applies.

Emergency number: 911

Side effects and risks in the US

Get help now: call your local emergency number Severe or persistent vomiting or diarrhoea, severe abdominal pain or pressure, vomiting blood, or bleeding that will not stop are emergency warning signs, according to the American College of Emergency Physicians.10 Emergency numbers: 911 in the US and Canada, 999 in the UK, 998 or 999 in the UAE, 000 in Australia, 112 in India and Germany, 15 or 112 in France, 997 or 911 in Saudi Arabia.

Contact your prescriber or a doctor right away if nausea, vomiting or diarrhoea does not go away, or you get symptoms of gallbladder problems, as the US Zepbound Medication Guide advises.1

Read the full picture

Related questions

Did this answer your question?

Sources

  1. US Zepbound (tirzepatide) prescribing information and Medication Guide, revised August 2026. Eli Lilly
  2. US Wegovy (semaglutide) prescribing information, revised June 2026. DailyMed
  3. US Mounjaro (tirzepatide) prescribing information, revised August 2026. Eli Lilly
  4. US Ozempic (semaglutide) prescribing information, revised May 2026. DailyMed
  5. UK Wegovy 2.4 mg FlexTouch (semaglutide) SmPC, last updated on emc 22 September 2026. emc
  6. Gorgojo-Martínez JJ, et al. Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a multidisciplinary expert consensus. J Clin Med. 2022;12(1):145. PMC9821052
  7. US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Treatment for gas in the digestive tract. niddk.nih.gov
  8. US Pepto-Bismol (bismuth subsalicylate 262 mg chewable tablet) Drug Facts label, JC World Bell Wholesale Co., Inc. DailyMed
  9. Suarez FL, et al. Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon. Gastroenterology. 1998;114(5):923-929. PMID 9558280. University of Minnesota research record
  10. MedlinePlus, US National Library of Medicine. Recognizing medical emergencies, giving the American College of Emergency Physicians' warning signs. medlineplus.gov
  11. US Gas-X Extra Strength (simethicone 125 mg softgel) Drug Facts label, Haleon US Holdings LLC, updated March 14, 2025. DailyMed

Last checked Nov 9, 2026 · Next review due Nov 9, 2027 · Report an error

How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 9, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write